目的梳理胰腺癌诊断筛查方式的历史沿革,探究在中国人口基数大、经济处于发展中的背景下,如何实现胰腺癌的"早诊早治"。方法采用系统回顾的方法进行分析。计算机检索CNKI、VIP、WanFang Data、Web of Science、PubMed和EMbase数据库,同时由两名研究员独立检索百度搜索引擎,检索时限均从建库至2018年2月28日,搜集胰腺癌筛查方法及效果评价的相关报道,进行定性描述。结果共117篇文献纳入研究。国内对胰腺癌筛查方式的探索经历了萌芽、启蒙和成长三个阶段。现有筛查方式有临床表现、影像学方法、血清肿瘤标记物和分子生物学基因诊断四种,各有利弊。单一手段无法实现较高特异性和灵敏度,联合检测成为必然趋势。考虑到应用过程中的效益问题,在高危人群中进行筛查可以有效缩小人群范围,实现精准筛查。结论我国针对胰腺癌筛查方面的研究较国外有较大差距。筛查方法呈现多样性,联合检测是必然趋势。在高危人群中进行胰腺癌筛查将成为技术瓶颈下的突破口。 相似文献
Primary diffuse large B‐cell lymphoma of the central nervous system (CNS DLBCL) is a rare entity which is difficult to diagnose and treat. The histone methyltransferase EZH2 was reported to be involved in the tumorigenesis of systemic DLBCL but has not been implicated in primary CNS DLBCL. The clinicopathological features of 33 cases of primary CNS DLBCL and expression of EZH2 and Y641 mutation were assessed. The tumor cells of the majority cases resembled centroblasts, and intriguingly, three cases of rare anaplastic variant were observed. Immunophenotypically, 25/33 (75.8%) cases were non‐germinal center B‐cell‐like type. Several cases (10/33; 30.3%) co‐expressed BCL2 and MYC, 6/33 (18.2%) expressed both BCL6 and MYC, and 5/33 (15.2%) expressed BCL2, BCL6, and MYC. MYC expression alone and BCL2/MYC co‐expression were associated with poor prognosis. EZH2 was strongly expressed in all 33 cases independent of Y641 mutation and was significantly associated with the tumor proliferative index Ki67. However, no association was found between the level of EZH2 expression and outcomes of patients. In summary, the clinicopathological features including three rare anaplastic variant of primary CNS DLBCL are described. Strong expression of EZH2 in all the primary CNS DLBCL and association with high proliferative index provides further information for treatment and diagnosis of this distinctive entity. 相似文献
A one-step, mild procedure based on coaxial electrospinning was developed for incorporation and controlled release of two model proteins, BSA and lysozyme, from biodegradable core-shell nanofibers with PCL as shell and protein-containing PEG as core. The thickness of the core and shell could be adjusted by the feed rate of the inner dope, which in turn affected the release profiles of the incorporated proteins. It was revealed that the released lysozyme maintained its structure and bioactivity. The current method may find wide applications for controlled release of proteins and tissue engineering. 相似文献
Biodegradable core-shell structured fibers with poly(epsilon-caprolactone) as shell and bovine serum albumin (BSA)-containing dextran as core were prepared by coaxial electrospinning for incorporation and controlled release of proteins. BSA loading percent in the fibers and its release rate could be conveniently varied by the feed rate of the inner dope during electrospinning. With the increase in the feed rate of the inner dope, there was an associated increase in the loading percent and accelerated release of BSA. Poly(ethylene glycol) (PEG) was added to the shell section of the fibers to further finely modulate the release behavior of BSA. It was revealed that the release rate of BSA increased with the PEG percent in the shell section. By varying the feed rate of the inner dope and PEG content, most of BSA could be released from the core-shell structured fibers within the period of time ranging from 1 week to more than 1 month. The effect of the feed rate of the inner dope and addition of PEG into the shell section on the fiber morphology was also examined by scanning electron microscope. 相似文献
Clinical outcome of spinal cavernous malformation (SCM) varies because of its unclear natural history, and reliable prognostic prediction model for SCM patients is limited. The aim of the present study was to investigate potential factors that predict one-year neurological status in postoperative patients with SCM.
Methods
This was a multicenter prospective observational study in consecutive patients with SCMs. SCMs treated microsurgically between January 2015 and January 2021 were included. Outcome was defined as the American Spinal Injury Association Impairment Scale (AIS) grade at one year after operation. Multivariable analyses were used to construct the best predictive model for patient outcomes.
Results
We identified 268 eligible SCM patients. Neurological outcome had worsened from preoperative baseline in 51 patients (19.0%) at one year. In the multivariable logistic regression, the best predictive model for unfavorable outcome included symptom duration ≥ 26 months (95% CI 2.80–16.96, P < 0.001), size ≤ 5 mm (95% CI 1.43–13.50, P = 0.010), complete intramedullary (95% CI 1.69–8.14, P = 0.001), subarachnoid hemorrhage (95% CI 2.92–12.57, P < 0.001), AIS B (95% CI 1.91–40.93, P = 0.005) and AIS C (95% CI 1.12–14.54, P = 0.033).
Conclusions
Admission size of the lesion, morphology, symptom duration, AIS grade and the presence of subarachnoid hemorrhage were strong outcome predictors regarding prognostication of neurological outcome in postoperative patients with SCMs. A decision to surgically remove a symptomatic SCM should be justified by systematic analysis of all factors potentially affecting outcome.
弥漫大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)是最常见的非霍奇金淋巴瘤(non-hodgkin lymphoma),并且是一组在临床表现、组织形态和预后等多方面具有很大异质性的恶性肿瘤,其发病机制错综复杂。近年来表观遗传学修饰在DLBCL的发生、发展中的重要作用是研究的热点。本文综述了近年来组蛋白甲基转移酶EZH2和MLL2在弥漫大B细胞淋巴瘤中的最新研究进展,为从表观遗传学的角度认识和治疗弥漫大B细胞淋巴瘤提供新认识。 相似文献